company background image
HOLX * logo

Hologic BMV:HOLX * Stock Report

Last Price

Mex$1.21k

Market Cap

Mex$294.2b

7D

0%

1Y

n/a

Updated

03 Mar, 2024

Data

Company Financials +

Hologic, Inc.

BMV:HOLX * Stock Report

Market Cap: Mex$294.2b

HOLX * Stock Overview

Engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. More details

HOLX * fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 12.99% per year

Risk Analysis

Shares are highly illiquid

Significant insider selling over the past 3 months

Profit margins (13%) are lower than last year (22.2%)

Large one-off items impacting financial results


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Hologic, Inc. Competitors

Sonova Holding

SWX:SOON

CHF 15.0b

bioMérieux

ENXTPA:BIM

€13.6b

Olympus

TSE:7733

JP¥2.2t

Zimmer Biomet Holdings

NYSE:ZBH

US$18.3b

Price History & Performance

Summary of share price highs, lows and changes for Hologic
Historical stock prices
Current Share PriceUS$1,207.71
52 Week HighUS$1,265.13
52 Week LowUS$1,207.71
Beta1.02
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-21.17%
5 Year Change31.85%
Change since IPO36.31%

Recent News & Updates

Recent updates

Shareholder Returns

HOLX *MX Medical EquipmentMX Market
7D0%0%0%
1Yn/a0%0%

Return vs Industry: Insufficient data to determine how HOLX * performed against the MX Medical Equipment industry.

Return vs Market: Insufficient data to determine how HOLX * performed against the MX Market.

Price Volatility

Is HOLX *'s price volatile compared to industry and market?
HOLX * volatility
HOLX * Average Weekly Movementn/a
Medical Equipment Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in MX Market0%
10% least volatile stocks in MX Market0%

Stable Share Price: HOLX * has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine HOLX *'s volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19856,990Steve MacMillanwww.hologic.com

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.

Hologic, Inc. Fundamentals Summary

How do Hologic's earnings and revenue compare to its market cap?
HOLX * fundamental statistics
Market capMex$294.22b
Earnings (TTM)Mex$8.77b
Revenue (TTM)Mex$67.55b

33.6x

P/E Ratio

4.4x

P/S Ratio

Is HOLX * overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HOLX * income statement (TTM)
RevenueUS$3.97b
Cost of RevenueUS$1.55b
Gross ProfitUS$2.42b
Other ExpensesUS$1.91b
EarningsUS$515.10m

Last Reported Earnings

Dec 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.19
Gross Margin60.99%
Net Profit Margin12.98%
Debt/Equity Ratio55.0%

How did HOLX * perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/03 06:01
End of Day Share Price 2023/12/05 00:00
Earnings2023/12/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hologic, Inc. is covered by 51 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Charles ButlerBarclays